Brief: Ekso Bionics Says Q2 Revenue Rose 57% To $3.5 Million
28/07/2022 22:55
July 28 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS SECOND QUARTER 2022 RESULTS
* Q2 REVENUE ROSE 57 PERCENT TO $3.5 MILLION
* Q2 LOSS PER SHARE $0.23
Source text for Eikon: ID:nGNX3B7GrP
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Chronoscale To Divest Ekso Bionics And Focus On Cloud Business
Brief: Applied Digital Completes Separation Of Cloud Business, Establishing Chronoscale As Independent Public Company
Brief: Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate
Applied Digital jumps after Q2 revenue beats on AI data center demand
Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump